No, although the patient and caregiver consent, the patient has no known mutation and complete clinical response


  • Start complement inhibition (eculizumab/ravulizumab)

Map: TMA (792)
Node: 16365
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway

  • Det kommer klaging fra foreldrene som har observert henne ved henting og bringing situasjon
  • Ignore the wound complaint and focus solely on blood glucose.
  • No, although the patient and caregiver consent, the patient has no known mutation and complete clinical response

Reminder

FINISH

Time is up